This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leitner, W. W. Articles by Restifo, N. P. Search for Related Content PubMed PubMed Citation Articles by Leitner, W. W. Articles by Restifo, N. P.

Enhancement of Tumor-specific Immune Response with Plasmid DNA Replicon Vectors

National Cancer Institute, NIH, Bethesda, Maryland 20892-1502 [W. W. L., H. Y., N. P. R.], and Center for Gene Therapy, Chiron Corporation, Emeryville, California 94608 [D. A. D., T. W. D.]

To enhance the immunogenicity of nucleic acid vaccines, we used plasmid DNA vectors that contained replicons derived from the prototype alphavirus, Sindbis, and another alphavirus, Semliki Forest virus. When transfected into cells or injected directly into animal muscle, these plasmids launch a self-replicating RNA vector (replicon) which in turn directs the expression of a model tumor antigen. Immunization with plasmid DNA replicons elicited immune responses at doses 100 to 1000-fold lower than conventional DNA plasmids and effectively treated mice bearing an experimental tumor expressing the model antigen. Significantly, replicon-based DNA plasmids did not produce a greater quantity of antigen; instead, antigen production differed qualitatively. Plasmid DNA replicons mediated antigen production that was homogeneous in all transfected cells and associated with the apoptotic death of the host cells. Because of their safety and efficacy, plasmid DNA replicons may be useful in the development of recombinant vaccines for infectious diseases and cancer.

This article has been cited by other articles:

				K. Ljungberg, A. C. Whitmore, M. E. Fluet, T. P. Moran, R. S. Shabman, M. L. Collier, A. A. Kraus, J. M. Thompson, D. C. Montefiori, C. Beard, et al. Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine J. Virol., December 15, 2007; 81(24): 13412 - 13423. [Abstract] [Full Text] [PDF]

				R. J. Durso, S. Andjelic, J. P. Gardner, D. J. Margitich, G. P. Donovan, R. R. Arrigale, X. Wang, M. F. Maughan, T. L. Talarico, R. A. Olmsted, et al. A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses Clin. Cancer Res., July 1, 2007; 13(13): 3999 - 4008. [Abstract] [Full Text] [PDF]

				S.-Q. Sun, X.-T. Liu, H.-C. Guo, S.-H. Yin, Y.-J. Shang, X. Feng, Z.-X. Liu, and Q.-G. Xie Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus J. Gen. Virol., March 1, 2007; 88(3): 842 - 848. [Abstract] [Full Text] [PDF]

				J. H. Aberle, S. W. Aberle, R. M. Kofler, and C. W. Mandl Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis Virus J. Virol., December 15, 2005; 79(24): 15107 - 15113. [Abstract] [Full Text] [PDF]

				S. C. Derrick, A. L. Yang, and S. L. Morris Vaccination with a Sindbis Virus-Based DNA Vaccine Expressing Antigen 85B Induces Protective Immunity against Mycobacterium tuberculosis Infect. Immun., November 1, 2005; 73(11): 7727 - 7735. [Abstract] [Full Text] [PDF]

				A. Diatta, E. Piver, C. Collin, P. Vaudin, and J.-C. Pages Semliki Forest virus-derived virus-like particles: characterization of their production and transduction pathways J. Gen. Virol., November 1, 2005; 86(11): 3129 - 3136. [Abstract] [Full Text] [PDF]

				G. R. Otten, M. Schaefer, B. Doe, H. Liu, I. Srivastava, J. zur Megede, J. Kazzaz, Y. Lian, M. Singh, M. Ugozzoli, et al. Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins J. Virol., July 1, 2005; 79(13): 8189 - 8200. [Abstract] [Full Text] [PDF]

				S. Demaria, F. R. Santori, B. Ng, L. Liebes, S. C. Formenti, and S. Vukmanovic Select forms of tumor cell apoptosis induce dendritic cell maturation J. Leukoc. Biol., March 1, 2005; 77(3): 361 - 368. [Abstract] [Full Text] [PDF]

				E. K. L. Nordstrom, M. N. E. Forsell, C. Barnfield, E. Bonin, T. Hanke, M. Sundstrom, G. B. Karlsson, and P. Liljestrom Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1 J. Gen. Virol., February 1, 2005; 86(2): 349 - 354. [Abstract] [Full Text] [PDF]

				C. Rheme, M. U. Ehrengruber, and D. Grandgirard Alphaviral cytotoxicity and its implication in vector development Exp Physiol, January 1, 2005; 90(1): 45 - 52. [Abstract] [Full Text] [PDF]

				M. M. Whitmore, M. J. DeVeer, A. Edling, R. K. Oates, B. Simons, D. Lindner, and B. R. G. Williams Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity Cancer Res., August 15, 2004; 64(16): 5850 - 5860. [Abstract] [Full Text] [PDF]

				K. Teramoto, K. Kontani, Y. Ozaki, S. Sawai, N. Tezuka, T. Nagata, S. Fujino, Y. Itoh, O. Taguchi, Y. Koide, et al. Deoxyribonucleic Acid (DNA) Encoding a Pan-Major Histocompatibility Complex Class II Peptide Analogue Augmented Antigen-specific Cellular Immunity and Suppressive Effects on Tumor Growth Elicited by DNA Vaccine Immunotherapy Cancer Res., November 15, 2003; 63(22): 7920 - 7925. [Abstract] [Full Text] [PDF]

				K. Devaraj, M. L. Gillison, and T.-C. Wu DEVELOPMENT OF HPV VACCINES FOR HPV-ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA Crit. Rev. Oral. Biol. Med., September 1, 2003; 14(5): 345 - 362. [Abstract] [Full Text] [PDF]

				J. R. Kirman, T. Turon, H. Su, A. Li, C. Kraus, J. M. Polo, J. Belisle, S. Morris, and R. A. Seder Enhanced Immunogenicity to Mycobacterium tuberculosis by Vaccination with an Alphavirus Plasmid Replicon Expressing Antigen 85A Infect. Immun., January 1, 2003; 71(1): 575 - 579. [Abstract] [Full Text] [PDF]

				K. Haupt, M. Roggendorf, and K. Mann The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy Experimental Biology and Medicine, April 1, 2002; 227(4): 227 - 237. [Abstract] [Full Text] [PDF]

				M. P. Velders, S. McElhiney, M. C. Cassetti, G. L. Eiben, T. Higgins, G. R. Kovacs, A. G. Elmishad, W. M. Kast, and L. R. Smith Eradication of Established Tumors by Vaccination with Venezuelan Equine Encephalitis Virus Replicon Particles Delivering Human Papillomavirus 16 E7 RNA Cancer Res., November 1, 2001; 61(21): 7861 - 7867. [Abstract] [Full Text] [PDF]

				W.-F. Cheng, C.-F. Hung, C.-Y. Chai, K.-F. Hsu, L. He, C. M. Rice, M. Ling, and T.-C. Wu Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Mycobacterium tuberculosis Heat Shock Protein 70 Gene to an Antigen Gene J. Immunol., May 15, 2001; 166(10): 6218 - 6226. [Abstract] [Full Text] [PDF]

				W.-F. Cheng, C.-F. Hung, C.-Y. Chai, K.-F. Hsu, L. He, M. Ling, and T.-C. Wu Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Herpes Simplex Virus Type 1 VP22 Protein to Antigen J. Virol., March 1, 2001; 75(5): 2368 - 2376. [Abstract] [Full Text]

				H. Zheng, P. Palese, and A. García-Sastre Antitumor Properties of Influenza Virus Vectors Cancer Res., December 1, 2000; 60(24): 6972 - 6976. [Abstract] [Full Text]